Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Suboxone

Phase 3Small molecule

Suboxone is one of 40 small molecule programs targeting Hepatitis C. It is currently in Phase 3.

3

Indications

10

Total Trials

1

Active Trials

39

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hepatitis CActive, not recruiting

OpioidEnrolling by invitation

TelemedicineCompleted

Hepatitis CPreclinical

Active, not recruiting

OpioidPhase 3

Enrolling by invitation

TelemedicinePreclinical

Completed

Competition

Competitive Landscape

35 competitors in Hepatitis C

#DrugCompanyPhaseTrials

Sovaldi

Actos

Selzentry

Neoral

Afinitor

Prograf

VVeloxis Pharmaceuticals

Epivir

GGlaxo Dba Glaxosmithkline

Nuvigil

NNuvo Research GmbH

Retrovir

BBp Consulting, Inc

Suboxone

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Buprenorphine1 trial

Buprenorphine Naltrexone-P1 A-Cocaine

Completed·NNational Institute on Drug Abuse (NIDA)·Phase 1·NCT00733720·8 enrolled

Efficacy1 trial

Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)

Completed·VVirginia Polytechnic Institute and State University·N/A·NCT00929253·170 enrolled

Opiate Dependence1 trial

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Completed·—·Phase 3·NCT02696096·21 enrolled

Hepatitis C1 trial

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP

Completed·—·N/A·NCT05108935·17 enrolled

Acceptability1 trial

A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)

Completed· Merck & Co. logo

Merck & Co.·Phase 4·NCT00604188·188 enrolled

5 more indications

Opioid Use Disorder1 trial

Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine

Completed·IIndivior Inc.·Phase 3·NCT02357901·665 enrolled

Opioid1 trial

Houston Emergency Opioid Engagement System

Enrolling by invitation·TThe University of Texas Health Science Center, Houston·Phase 4·NCT03396276·3,000 enrolled

Telemedicine1 trial

Providing Suboxone and PrEP Using Telemedicine

Completed·—·N/A·NCT04521920·17 enrolled

Single Ascending Dose1 trial

Single Ascending Dose Study of RBP-6000

Completed·IIndivior Inc.·Phase 1·NCT03002961·48 enrolled

Unspecified1 trial

INDV-6001 Multiple-Dose Pharmacokinetic Study

Completed·IIndivior Inc.·Phase 2·NCT06576843·123 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Suboxone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Suboxone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Suboxone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Merck & Co. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Merck & Co.

Related News